MedPath

Corticosteroid Therapy for Persistent Synovitis in Acute Septic Arthritis on Native Joint

Conditions
Arthritis, Septic
Registration Number
NCT05531227
Lead Sponsor
University Hospital, Strasbourg, France
Brief Summary

Acute septic arthritis is a rare but life-threatening and functionally serious disease. The improvement or disappearance of pain and functional recovery are sometimes difficult to obtain, with in some cases the persistence of synovitis due to a prolonged local inflammatory response, despite early and effective treatment. The consequences are significant for patients with often significant chronic pain, repercussions on autonomy and/or profession. An unfavorable evolution with joint destruction and need for replacement by a prosthesis is not uncommon.

Corticosteroid therapy is widely used in rheumatology in similar tables, for the purpose of drug synovectomy, with good results. The risk of infection remains the main contraindication to its use.

There are very few studies on its use in septic arthritis, either fundamentally or in humans, for which there are no data in adults. However, these have shown results encouraging the investigators not to neglect this therapy.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Complete regression of the pain in a fast way6 months after treatment with corticosteroids
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Service de Chirurgie Orthopédique Septique - CHU de Strasbourg - France

🇫🇷

Strasbourg, France

Service de Chirurgie Orthopédique Septique - CHU de Strasbourg - France
🇫🇷Strasbourg, France
Jeannot GAUDIAS, MD
Principal Investigator
Saïd CHAYER, PhD, HDR
Contact
said.chayer@chru-strasbourg.fr
Alia BARTHEL, MD
Sub Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.